Losartan-hctz 100-12.5 MG tab 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6RG3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,015
Award facts
- Contract value 100% obligated
- $20,014.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,014.85 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed price delivery order represents a non-competitive award under an existing contract vehicle and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Losartan-HCTZ is a combination antihypertensive medication commonly used to treat high blood pressure and is a standard pharmaceutical product maintained in military and federal healthcare supply chains.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated capability to fulfill federal medical procurement requirements through open competition and maintains extensive experience delivering both brand-name and generic medications across multiple therapeutic domains to federal customers.
Quick answers
Who was awarded contract SPE2DR26F6RG3?
SPE2DR26F6RG3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F6RG3 worth?
The government has obligated $20,015 on SPE2DR26F6RG3.
Is contract SPE2DR26F6RG3 an order under another contract?
Yes. SPE2DR26F6RG3 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RG3 competed?
The extent of competition for SPE2DR26F6RG3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award